BackCentessa Pharmaceuticals plc Overview
Centessa Pharmaceuticals plc - ADR

Centessa Pharmaceuticals plc Target Price

Where could CNTA trade next? Consensus target price: $42.

Get informed when a big investor buys or sells

+ Follow

Share Price

$40.5

Average Target Price

$42.003.7% upside

1 analysts in the last 4 months

High: $42 | Low: $42

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-04-20Wells Fargo$423.7% upsideOpen
2026-02-23Wolfe Research$401.2% downsideOpen
2026-01-29Truist Financial$386.2% downsideOpen
2026-01-08Truist FinancialDanielle Brill$3318.5% downsideOpen
2026-01-05Needham$386.2% downsideOpen
2025-12-01B.Riley FinancialMayank Mamtani$423.7% upsideOpen
2025-11-05Truist FinancialDanielle Brill$3025.9% downsideOpen
2025-10-28StephensSudan Loganathan$3513.6% downsideOpen
2025-09-02Wells Fargo$3123.5% downsideOpen
2025-05-08Chardan CapitalRudy Li$3025.9% downsideOpen
2025-05-08OppenheimerAndreas Argyrides$685.2% downsideOpen
2025-03-07Morgan Stanley$2733.3% downsideOpen
2024-11-15GuggenheimDebjit Chattopadhyay$2830.9% downsideOpen
2024-09-19Morgan StanleyJeffrey Hung$2635.8% downsideOpen
2024-09-11JefferiesKelly Shi$1953.1% downsideOpen
2024-09-10BMO CapitalKostas Biliouris$2050.6% downsideOpen
2024-08-14BMO CapitalKostas Biliouris$1563% downsideOpen

Centessa Pharmaceuticals plc (CNTA) FAQ

Centessa Pharmaceuticals plc (CNTA) currently reports a target price of $42. Use the charts on this page to explore Centessa Pharmaceuticals plc's target price history and peer comparisons.

Analysts' average 12-month price target for Centessa Pharmaceuticals plc is $42, about 3.7% upside from the current share price of $40.5. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $42, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Centessa Pharmaceuticals plc, and consider following CNTA for alerts when major investors trade the stock.

Centessa Pharmaceuticals plc is classified in the Healthcare sector. On target price, it currently shows $42. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CNTA with unrelated industries.